Grant - Medannex
Investment Firm
Overview
Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1.
Announced Date
Jul 25, 2024
Funding Type
Grant
Highlights
Location
Europe
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
 Innovate UK |
Round Details and Background
Medannex raised $403271 on 2024-07-25 in Grant
Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 06, 2019 |  Series B - Medannex | 2 | - | 13.5M |
| Jul 25, 2024 | Grant - Medannex | 1 | - | 403.3K |
Recent Activity
There is no recent news or activity for this profile.